KU-55933 (ATM Kinase Inhibitor)

Catalog No.S1092

For research use only.

KU-55933 (ATM Kinase Inhibitor) is a potent and specific ATM inhibitor with IC50/Ki of 12.9 nM/2.2 nM in cell-free assays, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR. KU‑55933 (ATM Kinase Inhibitor) inhibits the activation of autophagy‑initiating kinase ULK1 and results in a significant decrease of autophagy.

KU-55933 (ATM Kinase Inhibitor) Chemical Structure

CAS No. 587871-26-9

Selleck's KU-55933 (ATM Kinase Inhibitor) has been cited by 269 publications

Purity & Quality Control

Choose Selective ATM/ATR Inhibitors

Other ATM/ATR Products

Biological Activity

Description KU-55933 (ATM Kinase Inhibitor) is a potent and specific ATM inhibitor with IC50/Ki of 12.9 nM/2.2 nM in cell-free assays, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR. KU‑55933 (ATM Kinase Inhibitor) inhibits the activation of autophagy‑initiating kinase ULK1 and results in a significant decrease of autophagy.
Targets
ATM [1]
(Cell-free assay)
12.9 nM
In vitro

KU-55933 inhibits DNA-PK and PI3K with IC50 of 2.5 μM and 16.6 μM, respectively. Besides, KU-55933 also prevents the activity of mTOR with IC50 of 9.3 μM. KU-55933 is active at the cellular level in ablating a well-characterized ATM-dependent phosphorylation event. KU-55933 has a dose-dependent effect in inhibiting this ATM-dependent phosphorylation event with IC50 of 300 nM. KU-58050 does not prevent the ATM-dependent phosphorylation of p53 serine 15 until a dose of 30 μM. Addition of KU-55933 has no appreciable effects on UV-induced phosphorylation of H2AX on serine 139, NBS1 on serine 343, CHK1 on serine 345, and SMC1 on serine 966. In stark contrast to the UV responses, KU-55933 ablates the ionizing radiation-induced phosphorylation of these ATM substrates. KU-55933 sensitizes HeLa cells to a range of ionizing radiation doses. [1] KU-55933 inhibits the phosphorylation of Akt induced by growth factors in cancer cells. KU-55933 suppresses the proliferation of cancer cells. Furthermore, suppression of ATM by KU-55933 improves survival, probably via prevention of downstream activation of TAp63α. [2]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
DU-145 M4TZTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFWweHRKSzVyPUOuNlc{PTJizszN M3jBTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
HuO-3N1 NWjFU24{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2nzRmlEPTB;ND6xO|E1OiEQvF2= MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
LAMA-84 NXS5[4h7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHrCSXlKSzVyPUSuOVg1PjVizszN M3fMNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
CAL-72 NWDObIRwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEjWVZNKSzVyPUWuOFgxQDRizszN NWPsS|VqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
LoVo NIjicnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUjJR|UxRTZwOUOyN|kh|ryP M3HqdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
HH NUX2cYxwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIP6c2FKSzVyPUiuNlc3PzFizszN M2TOUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
SK-MEL-3 MkewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF3GXnpKSzVyPUiuNlg2PzVizszN M2HkSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
KM12 M2TaeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4Sxd2lEPTB;OT6yNVE1OiEQvF2= MlzWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
NCI-H1437 MmjjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkHzTWM2OD17LkiwPVch|ryP Mm\UQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
NCI-H1838 M4\nSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NG\2TXJKSzVyPUGxMlE5PjVizszN NXPxTWdwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
J-RT3-T3-5 NF:5T3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUXJR|UxRTFzLkK0NVch|ryP NYTDWpBrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
GOTO MkTSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXHJR|UxRTFzLk[5PVYh|ryP NWXVb5BoRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
LB2241-RCC M3e4dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGmyRWtKSzVyPUGxMlcyQDZizszN MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
ES7 NWnuTodZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEf3W3ZKSzVyPUGxMlc5QCEQvF2= NGK4NFY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
KP-N-YS MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVLJR|UxRTF{Lk[zOVQh|ryP NWTLTWFIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
CAL-12T M2[0S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYDJR|UxRTF|Lk[xO{DPxE1? NHOyO5k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
COLO-684 NUO4R3A6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXj0Tm1zUUN3ME2xOE4yPTZ7IN88US=> MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
DOK MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVX5[4ZvUUN3ME2xOU4{OzJ7IN88US=> NILRZYI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
Hs-578-T NWP6cGpiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MljaTWM2OD1zNT60NVgzKM7:TR?= NHjTOYQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
D-423MG M1np[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHj0OpRKSzVyPUG1MlUzOzZizszN NVPFOot2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
DBTRG-05MG Ml7GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3fVdWlEPTB;MUWuOlEyOSEQvF2= NWO0NXRLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
VM-CUB-1 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHfKeWNKSzVyPUG1Mlk5PDlizszN MnP4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
KG-1 MkP0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX\JR|UxRTF4LkC5PVYh|ryP M2WwSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
8305C M2KyWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2HNVGlEPTB;MU[uNVg5QSEQvF2= NEO4UJg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HuH-7 MnTMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHjkd4tKSzVyPUG2MlI3PzRizszN MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
LXF-289 NUHYRXJXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEfR[5pKSzVyPUG2MlI4PDdizszN NWPBSpBbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
NCI-H1793 NH\sOo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYjJR|UxRTF4LkS3NVIh|ryP NEHuUpU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
ChaGo-K-1 M2HkWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlnZTWM2OD1zNj62OVY5KM7:TR?= NV\qZmRLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
GCIY MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUHRXHhSUUN3ME2xOk44QTB3IN88US=> NYrjPJVYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
SK-MEL-28 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX\KSolrUUN3ME2xO{4xPDd3IN88US=> MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
NCI-SNU-1 M3:1bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXTJR|UxRTF5LkGyOlkh|ryP NIK0NFU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
CTB-1 MlzJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHrqOmZKSzVyPUG3MlIzPTlizszN MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
NCI-H82 NIDtUW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3OzTmlEPTB;MUeuOFU4OyEQvF2= NHTueok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HCC2998 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3PYTWlEPTB;MUeuOlc{OyEQvF2= NYPwb25JRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
NCI-H2030 M{DrVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1;hOGlEPTB;MUiuNVk6PyEQvF2= M{TtcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
HuP-T3 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmHRTWM2OD1zOD61PFg5KM7:TR?= MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
697 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFTSdlVKSzVyPUG5MlAzODFizszN NHjGV2I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
MLMA NWLUTGdyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4fRUGlEPTB;MUmuNFU2PyEQvF2= NGrQXXM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HCC70 MkTiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV7udZFpUUN3ME2xPU41QDlizszN M4DpelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
A704 NWjBfGFjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M32zT2lEPTB;MUmuPFMxPSEQvF2= NFjTc5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
D-283MED NITzeJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFuwdIRKSzVyPUKwMlU{OzlizszN NWH2OYdwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
U031 Mn\US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTJzLkG0PFkh|ryP NVPsb|JKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
HSC-3 NV;jXmM{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3nh[WlEPTB;MkGuNVg{PSEQvF2= M3XUbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
JVM-3 MoGzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGKyfYNKSzVyPUKyMlUxPiEQvF2= NFu0fJA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
Mewo MmfUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTJ{LkWwO|Mh|ryP M12yRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
YH-13 MnTUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXrh[phlUUN3ME2yNk42OTJ|IN88US=> M4nFSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
LB1047-RCC M3PMbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFfCNWhKSzVyPUKyMlU5PzlizszN NGThVXA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HCC2157 NV35UYlFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NELXdWNKSzVyPUKyMlgxPTRizszN NE\Nc209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
SNU-449 M4Dre2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEfyUIpKSzVyPUKyMlg4PDhizszN MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
Ramos-2G6-4C10 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3z5SGlEPTB;MkKuPVYh|ryP NGPpU|Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
CHL-1 NET5NGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXTJR|UxRTJ|LkeyPVIh|ryP NHrPfmQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
SK-MEL-30 M1rkTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4XWbmlEPTB;MkSuOFY3OiEQvF2= M1HZbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
PANC-08-13 NXjySVBvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUfJR|UxRTJ3LkC5N|gh|ryP NXjOdYhkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
QIMR-WIL NX\sVJd{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYjTNXNEUUN3ME2yOU4yQDV6IN88US=> MkL1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
BFTC-905 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX3JR|UxRTJ3LkW5OFQh|ryP MmDEQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
GI-1 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NETsUIZKSzVyPUK1MlcxPTVizszN NFrMTJU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
MDA-MB-415 Mm\tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlfHTWM2OD1{Nj61NFM{KM7:TR?= NFW0VHE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
GT3TKB M1Hwd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVPo[|BVUUN3ME2yOk42OzR{IN88US=> MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
DEL Mn7tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3[1VmlEPTB;Mk[uPFM2PiEQvF2= M33hTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
KOSC-2 MlTES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWi0fFBUUUN3ME2yOk46ODd3IN88US=> NEWyblU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
RVH-421 Mkf2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGTwc4FKSzVyPUK3MlI6OjFizszN MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
EW-13 M4\o[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYLVbYdzUUN3ME2yO{41OzB6IN88US=> MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
639-V NHvGb3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFTscIVKSzVyPUK3MlUyOTlizszN MmX2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
A2780 NXHwSpRHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3fMSmlEPTB;MkeuOlQyKM7:TR?= MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
SW982 M{fYOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXvwZm5uUUN3ME2yO{46ODV{IN88US=> M{n4XVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
SW1710 Ml3QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlLqTWM2OD1{OD6wPVgyKM7:TR?= M4rOT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
HCC1569 NVfTbotZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2fmZmlEPTB;MkiuOFg6PyEQvF2= NUjBPItXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
MV-4-11 Mmn0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV;JR|UxRTJ6LkW3N|Uh|ryP NGHRSJE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
BHT-101 M{fOTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX\0NY9EUUN3ME2yPE43PTd{IN88US=> MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
Ca9-22 NFPicXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlrWTWM2OD1{OD63NVQh|ryP M1ToRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
HAL-01 NVnISZM{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWDkSodtUUN3ME2yPE44PjF3IN88US=> MnTGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
D-263MG M3rLbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWjJR|UxRTJ7LkO0OEDPxE1? MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
NEC8 M2C0RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1yzNGlEPTB;MkmuOVU1QCEQvF2= NWnFPYQxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
EKVX MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF7odlZKSzVyPUOxMlU5PDdizszN MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
EM-2 NVK4O4hzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlfmTWM2OD1|MT62N|A1KM7:TR?= MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
MFM-223 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUfJR|UxRTNzLkiwPVgh|ryP MkTvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
SK-PN-DW NF36V3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYLJR|UxRTN{LkG0NFYh|ryP NIfDdG89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HuO9 NH7ZeJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWHJR|UxRTN{LkWyPFIh|ryP M1\3SlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
MHH-PREB-1 MlrCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYPtRXNtUUN3ME2zNk43OjN2IN88US=> Mn;4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
OVCAR-4 NFW0Z4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn;oTWM2OD1|Mj64N|Y{KM7:TR?= MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
NCI-H1648 NID3e4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlnGTWM2OD1|Mj64OlUyKM7:TR?= NGq3NXg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
MKN1 M{K2Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV3JR|UxRTN2LkGxNFEh|ryP MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
KYSE-450 Mo\qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYPJR|UxRTN2Lk[0OFQh|ryP Ml7YQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
ES8 NEXCcWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MljwTWM2OD1|ND64PVc2KM7:TR?= NYfVNYRTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
MS-1 NFz3dJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mm\3TWM2OD1|ND65OVU1KM7:TR?= M{ntRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
HOP-92 NWT1VmZ7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmC2TWM2OD1|NT65Nlc4KM7:TR?= NUexWXprRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
SKG-IIIa MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{XGc2lEPTB;M{[uNlU3OSEQvF2= NYrne3hkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
TE-11 MnXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mkn2TWM2OD1|Nj61NlQ{KM7:TR?= M3P4c|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
SK-NEP-1 M2Pje2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHvQOYVKSzVyPUO3MlY4PDRizszN Mo\yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
DB NHrOXHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWXJR|UxRTN5LkmxPFUh|ryP MlznQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
IA-LM NUi1bZRFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYrJR|UxRTN6LkCyN|kh|ryP Mn3XQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
COLO-829 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn[2TWM2OD1|OD60NVU6KM7:TR?= M37tNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
TGBC11TKB MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEnmW3pKSzVyPUO5MlE1ODhizszN M1HLOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
CAL-51 M{\1PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIPMV3FKSzVyPUSwMlA3OTJizszN MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
NCI-H2228 NWrmRpl2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEDGPItKSzVyPUSwMlM3PjJizszN M{nxN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
C32 Mo\MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnTCTWM2OD12MD60NFI1KM7:TR?= NELncmM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
KU-19-19 NXrGOoJDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXTJR|UxRTRyLke2PFMh|ryP NXmwbXhORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
KNS-62 M3fySWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYHDPZB2UUN3ME20NE45OzhzIN88US=> NXPjb2JwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
FADU NFrTT4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1zqUWlEPTB;NEGuNlUxOiEQvF2= M2niOVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
CAL-33 NUjhOWZCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml;NTWM2OD12Mj62O|Q6KM7:TR?= NXGxPIlqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
CHP-134 NEPJ[4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX\JR|UxRTR{Lki0PVYh|ryP MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
HDLM-2 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mo[2TWM2OD12Mj65NFg1KM7:TR?= MmjxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
NBsusSR MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHzQdXhKSzVyPUSzMlA4OjVizszN MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
SW954 NVfjO5V6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml3jTWM2OD12Mz6xNFU{KM7:TR?= MmjFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
HCC1806 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGjtOXpKSzVyPUSzMlQyOSEQvF2= M3jaelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
VMRC-RCZ MnLiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFjkWWhKSzVyPUSzMlQ2QDZizszN M{WzZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
A549 M3q5bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1nORWlEPTB;NEOuPVMyKM7:TR?= M2PsNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
NKM-1 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX3JR|UxRTR|Lkm1OVgh|ryP MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
DMS-273 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M164SWlEPTB;NESuO|U3PyEQvF2= NGm2NZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
TYK-nu MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnfZTWM2OD12NT6xNlM1KM7:TR?= M4nDfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
KALS-1 MlH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHrhblFKSzVyPUS1MlE1PiEQvF2= NYL3bog5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
A101D M3f2cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV\5[ZJuUUN3ME20OU41PDV4IN88US=> MmToQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
G-361 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWDMTVVjUUN3ME20Ok4zOTN6IN88US=> MojZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
KARPAS-299 NYLhSmR4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIDIZVVKSzVyPUS2MlM2OTZizszN NXKwWFBCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
RS4-11 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHjt[WNKSzVyPUS2MlU1OiEQvF2= M3[xZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
HT-1376 Ml3OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2rHfmlEPTB;NE[uO|QzPiEQvF2= MonzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
SK-N-AS MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M322O2lEPTB;NE[uO|gzOiEQvF2= NH\n[ng9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
MG-63 NUfBUIJFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXPJR|UxRTR4LkmwN|Yh|ryP MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
EPLC-272H NF\3RplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M17FTWlEPTB;NE[uPVUxOyEQvF2= NY[yboJJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
BALL-1 MoqzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIPNSXVKSzVyPUS3Mlg{OiEQvF2= Mn24QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xd4f3MoVjcS6jYz71b{9kcGWvYnyvZ49ueG:3bnTfdoVxd3K2X3PhdoQwS0iHTVLMNlIzOTB{Lze+V2FPT0WUPD;hQi=>
LCLC-97TM1 NIPO[lVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWPUPHpvUUN3ME20PE4zODJizszN NEHOUoI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HO-1-N-1 NGPaZWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{m3fWlEPTB;NEiuPVY4PiEQvF2= NUTYe5hRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:ve5d4NmWkaT7hZ{52cy:laHXtZoww[2:vcH;1coRgemWyb4L0Y4NiemRxQ1jFUWJNOjJ{MUCyM{c,W0GQR1XSQE9iRg>?
MFE-280 NUHTN4FNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHXRcINKSzVyPUS5MlQ3OTdizszN M{DSXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4f3e{5m[mlwYXOueYsw[2inbXLsM4NwdXCxdX7kY5JmeG:{dG;jZZJlN0OKRV3CUFIzOjFyMj:nQnNCVkeHUkyvZV4>
NCI-H526 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEjv[ZlKSzVyPUS5MlgyPjNizszN NFXOSXI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
D-566MG NEXRVI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX3veZhSUUN3ME20PU46ODl4IN88US=> NIrZWIs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
BB30-HNC NI\mSGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHTLbHJKSzVyPUS5Mlk1QThizszN MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:5d4eu[YJqNmGlLoXrM4Np\W2kbD;jc41xd3WwZG;y[ZBwenShY3Hy[E9EUEWPQlyyNlIyODJxJ{7TRW5ITVJ:L3G+
SK-N-DZ MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NITjVldKSzVyPUWwMlA1QDFizszN NIPMRXM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;3e5cv\WKrLnHjMpVsN2OqZX3icE9kd22yb4Xu[H9z\XCxcoTfZ4Fz\C:FSFXNRmwzOjJzMEKvK|5USU6JRWK8M4E,
HepG2  M1TTcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoPXNVDDqM7:TR?= MUCyOEBp M2rocoJtd2OtczDTR{1KUUl|LXnu[JVk\WRiUzDwbIF{\SCjcoLld5Q> NVPhXHpPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW1NlcyOjNpPkK1OVI4OTJ|PD;hQi=>
HepG2  NIK0[pBHfW6ldHnvckBCe3OjeR?= NUWwPFMxOTEEoN88US=> M2XBR|I1KGh? M{C1WZN2eHC{ZYPz[ZMhfGinIIDoc5NxcG:{eXzheIlwdnNib3[gRXROKG:wIGPldlE6QDFuIFPob|Ehd25iU3XyN|Q2NCCFaHuyJI9vKFSqck[4MEBidmRiQ3TrNkBwdiCWeYKxOUBqdmS3Y3XkJIJ6KFOFLVnJTVM> M{HkRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NUK3NVI{Lz5{NUWyO|EzOzxxYU6=
KATO III  MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX7GWJNSOi53L{WvO{42KM7:TR?= MX\EUXNQ NYfwVZpw\W6qYX7j[ZMhfGinIITvfIlkcXS7IH;mJI9t[XCjcnni Mn3yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6NEG3NVgoRjJ2OESxO|E5RC:jPh?=
hTCEpi MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkHaNVAh|ryP MVvEUXNQ NVLDO4JleHKndnXueJMhfGinIHP5eI9x[XSqaXOg[YZn\WO2IH;mJGhUXi1z M3nHd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2M{ewPFM2Lz5{NEO3NFg{PTxxYU6=
MCF10A M3vze2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFnZVIQyOCEQvF2= NEniNFAzPCCq MnrFSG1UVw>? M2TBN5BwfGWwdHnheIV{KHSqZTDjfZRwfG:6aXPpeJkhd2ZiR1G= MkL2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzNUC1PVUoRjJ2MUWwOVk2RC:jPh?=
HL-60  MkTTSpVv[3Srb36gRZN{[Xl? M1ezUVExKM7:TR?= NWrwRmNPOC53IHi= MkLySG1UVw>? MkfWdoVlfWOnczDwbI9{eGixconsZZRqd25ib3[gR4hsOsLi NGS0dZQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{mzOFQyOSd-MkO5N|Q1OTF:L3G+
MCF-7 NGS4cWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWHWcY9mOS1zMEFOwG0> NFTqbW0zPCCq NIOwZ4dHSlN? M2i3NYlvcGmkaYTzJJRp\SClZXzsJJBzd2yrZnXyZZRqd25? NWj6Um4yRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOxPFU{PDdpPkKzNVg2OzR5PD;hQi=>
HeLa  NVXzcWZiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIHQUIMyNTFyMN88US=> M4TIVFI1KGh? MVnGRnM> NHjLfZJqdmirYnn0d{B1cGViY3XscEBxem:uaX\ldoF1cW:w Ml\RQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNzOEWzOFcoRjJ|MUi1N|Q4RC:jPh?=
SH-SY5Y NWLFe4VlTnWwY4Tpc44hSXO|YYm= NULBfFNrOTEEoN88UeKh MV2yOEBp MojHbY5pcWKrdIOgZ4xqd3G3aX7vcE1qdmS3Y3XkJJBpd3OyaH;yfYxifGmxbjDv[kBxPTN? NEfhRog9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mk[yO|I6PCd-MkK2NlczQTR:L3G+
IMR-32 M2Xtc2Z2dmO2aX;uJGF{e2G7 M375dVExyqEQvF5CpC=> NFP2[5ozPCCq NYLrNVFScW6qaXLpeJMh[2yrb4H1bY5wdC2rbnT1Z4VlKHCqb4PwbI9zgWyjdHnvckBw\iCyNUO= NF7Hfo89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mk[yO|I6PCd-MkK2NlczQTR:L3G+
A549 MmjVSpVv[3Srb36gRZN{[Xl? NWfEUnJJOTEEoN88UeKh NH72WIUyKGh? NITlRm9{fXCycnXzd4V{KE6jbn:tR48ucW6mdXPl[EBxPTNiYXPjeY12dGG2aX;u NUT5NZpbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK1OVk{OjFpPkKyOVU6OzJzPD;hQi=>
T47D  NYrJWIV5TnWwY4Tpc44hSXO|YYm= NFP1WpEzOMLibV2= MWWyOEBp NFftVpRFVVOR M3rvXJBz\X[nboTzJGlTNWmwZIXj[YQh\GWpcnHkZZRqd25ib3[gTe67Ss7z MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTF2NEiwOUc,OjFzNES4NFU9N2F-
A29 MEF NX3FW45lTnWwY4Tpc44hSXO|YYm= M4fQZlExyqEQvF5CpC=> MX2xbC=> M1XyPIJtd2Otc9MgeIhmKHCqb4PwbI9zgWyjdHnvckBw\iCDa4SgZZQhW2W{NEezxsA> MnftQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjByNUO3PFEoRjJyMEWzO|gyRC:jPh?=
MDA-MB-453  NWrINXk2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXW1MVQxKM7:TR?= MXy3NkBp MXHJR|UxKG:oIEGwJO69VQ>? M4S5[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMEWzO|gyLz5{MEC1N|c5OTxxYU6=
PC-3 MlvJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUO1MVQxKM7:TR?= MnzpO|IhcA>? NFPBUHVKSzVyIH;mJFExKM7:TR?= NX3NW2tsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCwOVM4QDFpPkKwNFU{PzhzPD;hQi=>
U2OS M1HvfmZ2dmO2aX;uJIF{e2G7 NUHkfYpoUW6qaXLpeIlwdiCxZjDBWG0hcW5iaIXtZY4hXTKRUzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHB3MzDwbI9{eGixconsZZRqd25iYYSgV4VzOTVicnXzbYR2\SxiSVO1NEA:KDBwMkWg{txONg>? M4i0UFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NkOyPVY2Lz5{Nk[zNlk3PTxxYU6=
MCF7 MUjGeY5kfGmxbjDhd5NigQ>? NIKwfWsyKGi{ MoD0TY5pcWKrdHnvckBw\iCDVF2gb4lv[XOnIHnuJIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiMTDodkBjgSCrbX31co9ndHWxcnXzZ4Vv[2ViYYPzZZktKEmFNUCgQUAxNjNizszNMi=> NVG1d2hGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[2N|I6PjVpPkK2OlMzQTZ3PD;hQi=>
BJ MlTUSpVv[3Srb36gZZN{[Xl? MXSxNEB2VQ>? MnnaNVAh\GG7cx?= NWfZTJFDW3WycILld5Nqd25ib3[gd4Vv\XOlZX7j[UBqdiCqdX3hckBDUiClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDj[YxtKG63bXLldkBifCBzMDD1UUBi\nSncjCxNEBl[Xm|IHL5JJNmdmW|Y3XuZ4UhemW4ZYLzZYwh[XO|YYm= NIXicXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNke2O|A5PSd-MU[3OlcxQDV:L3G+
BJ MkTySpVv[3Srb36gZZN{[Xl? MlT0NVAhfU1? MnzNNVAh\GG7cx?= NXPxR|hPUW6qaXLpeIlwdiCxZjDheIF5cWFidHXsZY5ocWWldHHzbYEudXW2YYTl[EBqdiCqdX3hckBDUiClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDj[YxtKG63bXLldkBifCBzMDD1UUBi\nSncjCxNEBl[Xm|IHL5JJNmdmW|Y3XuZ4UhemW4ZYLzZYwh[XO|YYm= NHTZTXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNke2O|A5PSd-MU[3OlcxQDV:L3G+
MCF7 NF7mU3NHfW6ldHnvckBie3OjeR?= NU\5N5dDOTBidV2= MUmxNEBucW6| M3LWNHNmdnOrdHn6ZZRqd25ib3[gbY5nemG{ZXStbY5lfWOnZDDEUmEh\GGvYXflJIlvKGi3bXHuJG1ETjdiY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJINwdG:weTDmc5Ju[XSrb36gZZQhOTBidV2gdJJmfHKnYYTl[EBnd3JiMUCgcYlveyCob3zsc5dm\CCkeTDpdpJi\GmjdHnvckBnd3JiNDDodpMhdWWjc4Xy[YQh[W[2ZYKgNVAh\GG7czDifUBkenm|dHHsJJZqd2yndDDzeIFqdmmwZzDhcoFtgXOrcx?= MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjZ|Mkm2OUc,OjZ4M{K5OlU9N2F-
SK-N-MC NHvVWIJyUFSVIHHzd4F6 NU\jeWF{eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> NXGwZmZTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Assay
Methods Test Index PMID
Western blot p-AKT(Ser473) / p-AKT(Thr308) ; PARP / Cleaved PARP / Caspase-3 / Cleaved caspase-3 ; ATM-S1981 / ATM / p-p53(S15) / p53 ; p21 / p27 / p53 22739265 20639198 20177072
Immunofluorescence p-S824 KAP1 / ZEBRA 28249048
In vivo Suppression of ATM-dependent STAT3 activation by KU-55933 enhances TRAIL-mediated apoptosis through up-regulation of surface DR5 expression, whereas suppression of both STAT3 and NF-κB appeares to be involved in down-regulation of cFLIP accompanied by an additional increase in apoptotic levels. The ATM inhibitor KU-55933 affectes TRAIL-mediated apoptosis more strongly than the JAK2 inhibitor, AG490, or overexpression of STAT3β. [3]

Protocol (from reference)

Kinase Assay:

[1]

  • Purified enzyme assays:

    ATM for use in the in vitro assay is obtained from HeLa nuclear extract by immunoprecipitation with rabbit polyclonal antiserum raised to the COOH-terminal 400 amino acids of ATM in buffer containing 25 mM HEPES (pH 7.4), 2 mM MgCl2, 250 mM KCl, 500 μM EDTA, 100 μM Na3VO4, 10% v/v glycerol, and 0.1% v/v Igepal. ATM-antibody complexes are isolated from nuclear extract by incubating with protein A-Sepharose beads for 1 hour and then through centrifugation to recover the beads. In the well of a 96-well plate, ATM-containing Sepharose beads are incubated with 1 μg of substrate glutathione S-transferase–p53N66 (NH2-terminal 66 amino acids of p53 fused to glutathione S-transferase) in ATM assay buffer [25 mM HEPES (pH 7.4), 75 mM NaCl, 3 mM MgCl2, 2 mM MnCl2, 50 μM Na3VO4, 500 μM DTT, and 5% v/v glycerol] at 37 °C in the presence or absence of inhibitor. After 10 minutes with gentle shaking, ATP is added to a final concentration of 50 μM and the reaction continued at 37 °C for an additional 1 hour. The plate is centrifuged at 250 × g for 10 minutes (4 °C) to remove the ATM-containing beads, and the supernatant is removed and transferred to a white opaque 96-well plate and incubated at room temperature for 1.5 hours to allow glutathione S-transferase-p53N66 binding. This plate is then washed with PBS, blotted dry, and analyzed by a standard ELISA technique with a phospho-serine 15 p53 antibody. The detection of phosphorylated glutathione S-transferase-p53N66 substrate is performed in combination with a goat antimouse horseradish peroxidase-conjugated secondary antibody. Enhanced chemiluminescence solution is used to produce a signal and chemiluminescent detection is carried out.

Cell Research:

[1]

  • Cell lines: U2OS cells
  • Concentrations: 10 μM
  • Incubation Time: 2 hours
  • Method:

    U2OS cells are exposed to ionizing radiation (3, 5, or 15 Gy) or UV (5 or 50 J/m2) and the ATM response determined by Western blot analysis of p53 serine 15 phosphorylation and stabilization of wild-type p53. Whole cell extracts are obtained from each time point, proteins separated by SDS-PAGE, and the ATM-specific increase in phosphorylated serine 15 measured with a p53 phospho-serine 15 specific antibody. Overall p53 stabilization with time is also observed with a p53-specific antibody (DO-1). Similarly, for studying ATM-dependent phosphorylations on H2AX, CHK1, NBS1, and SMC1, the following antibodies are used: CHK1 phospho-serine 345 and NBS1 phospho-serine 343 antibodies. Histone H2A (H-124) and CHK1 antibodies are also used, as well as SMC1 and SMC1 phospho-serine 966 antibodies. For determination of a cellular IC50 for KU-55933, the peak response time for p53 serine 15 phosphorylation of 2 hours is used to monitor inhibition of ATM. KU-55933 is titrated onto cells and preincubated for 1 hour before ionizing radiation. Using scanning densitometry, the percentage inhibition relative to vehicle control is calculated, and the IC50 value is calculated as for the in vitro determinations.

  • (Only for Reference)
Animal Research:

[3]

  • Animal Models: BALB/c nu/nu nude mice bearing LU1205 cells
  • Dosages: 10 μM
  • Administration: --
  • (Only for Reference)

Solubility (25°C)

In vitro

DMSO 33 mg/mL
(83.44 mM)
Water Insoluble
Ethanol Insoluble

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
5%DMSO+40%PEG300+5%Tween80+50%ddH2O
For best results, use promptly after mixing.

3.95 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 395.49
Formula

C21H17NO3S2

CAS No. 587871-26-9
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles C1COCCN1C2=CC(=O)C=C(O2)C3=C4C(=CC=C3)SC5=CC=CC=C5S4

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy KU-55933 (ATM Kinase Inhibitor) | KU-55933 (ATM Kinase Inhibitor) supplier | purchase KU-55933 (ATM Kinase Inhibitor) | KU-55933 (ATM Kinase Inhibitor) cost | KU-55933 (ATM Kinase Inhibitor) manufacturer | order KU-55933 (ATM Kinase Inhibitor) | KU-55933 (ATM Kinase Inhibitor) distributor